In-A Cho et al. [45] confirmed these effects in hypopharyngeal carcinoma, observing a 4.2-fold increase in apoptosis in FaDu cells treated with biochanin A. Moreover, FasL (a death receptor) and Bcl-2 decreased in a dose-dependent manner. The gene discussed is BCL2; the disease is hypopharyngeal carcinoma.